Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "neutral" rating re-affirmed by analysts at Bank of America Co..

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report